Prostate cancer screening in BRCA and Lynch syndrome mutation carriers

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

Volumn , Issue , 2013, Pages

  Castro, Elena ^a   Goh, Chee L ^a   Eeles, Rosalind A ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; G-T MISMATCH-BINDING PROTEIN; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN MSH2; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADENOCARCINOMA; AGED; BLOOD; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; EARLY DIAGNOSIS; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMAN; MALE; MIDDLE AGED; MISMATCH REPAIR; NEEDLE BIOPSY; NEOPLASTIC SYNDROMES, HEREDITARY; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; STATISTICS AND NUMERICAL DATA; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; AGED; BIOPSY, NEEDLE; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; DNA-BINDING PROTEINS; EARLY DETECTION OF CANCER; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASTIC SYNDROMES, HEREDITARY; NUCLEAR PROTEINS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK;

EID: 84952360747     PISSN: None     EISSN: 15488756     Source Type: Journal    
DOI: 10.1200/EdBook_AM.2013.33.e50     Document Type: Review

References (0)